Is Blueprint Medicines Corp. technically bullish or bearish?

Sep 20 2025 07:52 PM IST
share
Share Via
As of June 4, 2025, Blueprint Medicines Corp. is in a bullish trend supported by strong technical indicators, despite a bearish weekly RSI suggesting short-term caution, with year-to-date returns of 48.43% significantly outperforming the S&P 500's 12.22%.
As of 4 June 2025, the technical trend for Blueprint Medicines Corp. has changed from mildly bullish to bullish. The current stance is bullish with strong indicators supporting this view. The MACD is bullish on both weekly and monthly time frames, while the Bollinger Bands also indicate bullishness in both periods. Moving averages are bullish on the daily chart, and Dow Theory confirms a bullish trend on both weekly and monthly levels. However, the weekly RSI is bearish, which suggests some short-term weakness.

In terms of performance, the stock has returned 48.43% year-to-date compared to the S&P 500's 12.22%, and over three years, it has outperformed the benchmark with a return of 141.76% versus 70.41%. Overall, the technical indicators point to a bullish stance, albeit with some caution due to the bearish weekly RSI.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Blueprint Medicines Corp. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is Blueprint Medicines Corp. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
What does Blueprint Medicines Corp. do?
Jun 22 2025 06:48 PM IST
share
Share Via
How big is Blueprint Medicines Corp.?
Jun 22 2025 06:04 PM IST
share
Share Via